Clinical characteristics, diagnosis, treatment, and prognosis of Atezolizumab-induced encephalitis, aseptic meningitis or meningoencephalitis

Clinical characteristics, diagnosis, treatment, and prognosis of Atezolizumab-induced encephalitis, aseptic meningitis or meningoencephalitis

ObjectiveImmune checkpoint inhibitors (ICIs) have revolutionized cancer treatment and expanded the range of tumor indications. However, as the usage of this medication has increased, related adverse events are increasingly being identified. Among these, Atezolizumab-induced encephalitis, aseptic men...

Full description

Saved in:

Bibliographic Details
Main Authors:	Qingzi Yan, Yixiang Hu, Xiang Liu, Hong Xia
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-01-01
Series:	Frontiers in Human Neuroscience
Subjects:	atezolizumab PD-L1 encephalitis immune checkpoint inhibitor aseptic meningitis meningoencephalitis
Online Access:	https://www.frontiersin.org/articles/10.3389/fnhum.2025.1443463/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Unexpected cause of headache in a patient with Noonan syndrome: aseptic meningitis
by: Hacer Efnan Melek Arsoy, et al.
Published: (2024-09-01)

Clinical Features and Predictors of Lethal Outcome in Tick-Borne Encephalitis: A Retrospective Study from Lithuania
by: G. Rynkevič, et al.
Published: (2024-02-01)

An unusual cause of recurrent meningitis in a 17-year-old girl
by: K Nikitha, et al.
Published: (2020-01-01)

Pentraxin 3: a novel biomarker in pediatric central nervous system infections
by: Huda El-Kady, et al.
Published: (2025-01-01)

Neoadjuvant atezolizumab plus bevacizumab prior liver transplantation for hepatocellular carcinoma
by: Parissa Tabrizian, et al.
Published: (2025-02-01)

Second-line treatment patterns and outcomes in advanced HCC after progression on atezolizumab/bevacizumab
by: Meng Wu, et al.
Published: (2025-02-01)

Severe Cases of Tick-Borne Encephalitis in Northeastern Poland
by: Justyna Adamczuk, et al.
Published: (2024-12-01)

J-TAIL-2: A Prospective, Observational Study of Atezolizumab Combined With Carboplatin and Etoposide in Patients With Extensive-Stage SCLC in Japan
by: Eisaku Miyauchi, MD, PhD, et al.
Published: (2025-03-01)

Comparison of positive BioFire FilmArray meningitis/encephalitis (ME) panels, CSF cultures, CSF parameters, clinical presentation and in-patient mortality among patients with bacterial and fungal meningitis
by: Thein Myint, et al.
Published: (2025-02-01)

Effectiveness and safety of pembrolizumab, nivolumab, and atezolizumab as adjuvant therapy for high-risk muscle-invasive urothelial carcinoma: an indirect comparison
by: Wei Chen, et al.
Published: (2025-01-01)

Atezolizumab plus bevacizumab in patients with unresectable or metastatic mucosal melanoma: 3‐year survival update and multi‐omics analysis
by: Jie Dai, et al.
Published: (2025-01-01)

Treatment of neuro-invasive listeriosis: an overview
by: P. Gudeikaitė, et al.
Published: (2018-12-01)

Efficacy and safety of PD-1/PD-L1 inhibitors in advanced or recurrent endometrial cancer: a meta-analysis with trial sequential analysis of randomized controlled trials
by: Ji Ren, et al.
Published: (2025-01-01)

Toxic epidermal necrolysis induced by nivolumab therapy for unresectable intraperitoneal cancer
by: Hiroyoshi Nozaki, et al.
Published: (2025-01-01)

PD-L1 positive platelets mediate resistance to immune checkpoint inhibitors in patients with colorectal cancer
by: Jiacheng Li, et al.
Published: (2025-01-01)

Autoimmune pancerebellitis as an immune-related adverse event: an illustrative case
by: D. Valančius, et al.
Published: (2021-12-01)

Trends in Clinico-radiological and Laboratory Characteristics of All-Cause Meningoencephalitis in Western Rajasthan
by: Ravi Krishna Kanth, et al.
Published: (2024-12-01)

Effect of Proteinuria Before Lenvatinib Administration on Treatment Response After Atezolizumab Bevacizumab Combination Therapy
by: Hironori Ochi, et al.
Published: (2025-01-01)

Inosine enhances the efficacy of immune‐checkpoint inhibitors in advanced solid tumors: A randomized, controlled, Phase 2 study
by: Haiqing Zhao, et al.
Published: (2024-09-01)

Clinical Features and Rehabilitation Needs in Patients with Neuroinvasive West Nile Virus Infection: A Retrospective Analysis in an Area of High Incidence
by: Maria Chiara Maccarone, et al.
Published: (2025-01-01)

Increased serum soluble PD-l1 levels in patients with advanced stages of chronic kidney disease
by: Ayaka Hayashi, et al.
Published: (2025-01-01)

Efficacy and safety of immune checkpoint inhibitors in patients with advanced intrahepatic cholangiocarcinoma
by: Ziting Peng, et al.
Published: (2025-02-01)

Aseptic breast abscess syndrome as an example of neutrophilic dermatosis. Can an immune defect be the reason of a disease?
by: Przemysław Borowy, et al.
Published: (2024-11-01)

Lenvatinib versus sorafenib as second-line therapy following progression on atezolizumab–bevacizumab in patients with unresectable hepatocellular carcinoma: a multicenter retrospective study from Korea and Japan
by: Jaekyung Cheon, et al.
Published: (2025-01-01)

Neoadjuvant chemoradiotherapy up-regulates PD-L1 in radioresistant colorectal cancer
by: Sung Uk Bae, et al.
Published: (2025-03-01)

Immune-checkpoint-inhibitor therapy directed against PD-L1 is tolerated in the heart without manifestation of cardiac inflammation in a preclinical reversible melanoma mouse model
by: Caroline Schoenherr, et al.
Published: (2025-01-01)

Meningoencephalitis by Cryptococcus. Case presentation
by: Idalmis Reyes Rodríguez, et al.
Published: (2016-12-01)

Evaluating The Effect of Time and Temperature on The Ph, Titratable Acidity &Brix of Pasteurized LowTo-No Nectar Orange Drinks Packed in Paper Based Aseptic Packages
by: Azeen Kamal Al-Deen Mohammad, et al.
Published: (2022-06-01)

Glutamine-glutamate centered metabolism as the potential therapeutic target against Japanese encephalitis virus-induced encephalitis
by: Mengyuan Li, et al.
Published: (2025-01-01)

Review of the aetiologies of central nervous system infections in Vietnam
by: Hannah E. Brindle, et al.
Published: (2025-01-01)

Movement disorders in autoimmune encephalitis: Clinical spectrum, prognosis, and outcomes from an Indian cohort
by: Shreyashi Jha, et al.
Published: (2024-12-01)

Assessment of clinical prognosis in autoimmune encephalitis: Girona score
by: Gary Álvarez Bravo, et al.
Published: (2025-01-01)

Uncovering the role of tumor cGAS expression in predicting response to PD-1/L1 inhibitors in non-small cell lung cancer
by: Yuichi Ozawa, et al.
Published: (2024-11-01)

Electrochemical sensors for the detection of immune checkpoint related proteins and their role in cancer companion diagnostics
by: Louise Barnaby, et al.
Published: (2025-03-01)

Network Medicine‐Based Strategy Identifies Maprotiline as a Repurposable Drug by Inhibiting PD‐L1 Expression via Targeting SPOP in Cancer
by: Saisai Tian, et al.
Published: (2025-01-01)

Immunomediated Encephalitis: New Diagnoses on the Neurology–Psychiatry Interface
by: Daniel Damiani, et al.

Machine-Learning Parsimonious Prediction Model for Diagnostic Screening of Severe Hematological Adverse Events in Cancer Patients Treated with PD-1/PD-L1 Inhibitors: Retrospective Observational Study by Using the Common Data Model
by: Seok Jun Park, et al.
Published: (2025-01-01)

Three effective cases of transcatheter arterial embolization after atezolizumab and bevacizumab treatment for hepatocellular carcinoma: a case report
by: Koji Rinka, et al.
Published: (2025-01-01)

Evaluation and refinement of thresholds for early migration of total knee replacements as an estimator of late aseptic loosening: an updated systematic review of RSA and survival studies
by: Raymond Puijk, et al.
Published: (2025-01-01)

Evaluation of Treatment Outcomes Using dNLR and GNRI in Combination Therapy With Atezolizumab and Bevacizumab for Hepatocellular Carcinoma
by: Atsushi Naganuma, et al.
Published: (2025-01-01)